Pseudopseudohypoparathyroidism

A form of PSEUDOHYPOPARATHYROIDISM characterized by the same features except for the abnormal response to hormones such as PARATHYROID HORMONE. It is associated with paternally inherited mutant alleles of the ALPHA CHAIN OF STIMULATORY G PROTEIN.

Drugs by status

Phase 3 trials (1)

somatropin

Organizations

Organization Involved with Phase 4 Indications (1)

Harvard University

Organization Involved with Phase 3 Indications (3)

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
National Institutes of Health (NIH)
Johns Hopkins University

Organization Involved with Phase 2 Indications (1)

Vanderbilt University

Organization Involved with Other Experimental Indications (2)

Eli Lilly
University of Milan